Such risks and uncertainties include, but are not limited to potential adverse developments with respect to the Company’s efforts to obtain and maintain FDA and other required regulatory approvals limited, potential inability to fund the so sure, and if necessary, future of the company future of the company and unexpected delays with production and marketing activities linked. It is 31 for the Company’s Annual Report on Form 10-KSB for the year ended Made in December 2008 for a description of these and other risks and uncertainties.. About SyntheMed,SyntheMed , a biomaterials company engaged in the development and commercialization of anti-adhesion products on its proprietary bioresorbable polymer technology.

About adhesionsadhesions or scar tissue after virtually all open-heart surgical procedures occur, often resulting in the heart always at the sternum and other surrounding tissue surfaces. The presence of adhesions is a common and serious complication in secondary surgical procedures, increasing the length, cost and risk of the surgical procedure.Develop existing enthusiastic the key in the view of Prof. Van Hal. Getting stakeholders should be inspired no by the attempt to Are trying inspire excitement. It is much more effectively of linking existing enthusiastically to serves sustainable objectives. In practice, this means that SHOULD NOT BE to try to convince people not to preach but you should listen very carefully and by asking the right questions to detect that truly moves those involved The next trick is in that emotion with know about over to open up sustainability of. – Working towards sustainability can be achieved in so many ways that there are always a way to about help you solve a problem or achieve a goal.